Guidance for diagnostic testing of cases with severe acute hepatitis of unknown aetiology in children
This document provides guidance on diagnostic testing, molecular characterisation and metagenomic analysis for suspect cases of severe acute hepatitis of unknown aetiology.
Assessment of point-of-care testing devices for infectious disease surveillance, prevention and control – a mapping exercise
This document provides the final report of a mapping exercise undertaken as part of a wider study that was commissioned by ECDC and undertaken by RAND Europe between November 2019 and April 2020.
A scoping review of point-of-care testing devices for infectious disease surveillance, prevention and control
This document provides the final report of a scoping review undertaken as part of a wider study on the ‘Assessment of point of care testing devices for infectious disease surveillance, prevention and control’ that was commissioned by ECDC and undertaken by RAND Europe between November 2019 and April 2020.
Evaluation of the SARS-CoV-2 testing policy in Belgium from June to December 2021
The aim of this report is to independently evaluate the Belgian SARS-CoV testing policy to support an optimal and sustainable testing policy for public health purposes.
Considerations for the use of antibody tests for SARS-CoV-2 – first update
This report is the first update of a brief technical note that was developed at the request of the European Commission to inform the discussion on Digital Green Certificates to facilitate the safe and free movement of citizens within the EU during the COVID-19 pandemic.
Point of Care Testing for Infectious Disease in Europe: A Scoping Review and Survey Study
Hocking, L., George, J., Broberg, E.K., Struelens, M.J., Leitmeyer, K.C., Deshpande, A., Parkinson, S., Francombe, J., Morley, K.I., de Carvalho Gomes, H.
Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid and antibody tests up to 22 August 2020
Van Walle, I., Leitmeyer, K., Broberg, E.K.
Options for the use of rapid antigen tests for COVID-19 in the EU/EEA - first update
This document is the first update of the technical report ‘Options for the use of rapid antigen detection tests (RADTs) for COVID-19 in the EU/EEA’. It is intended to facilitate further discussions between Member States on the settings and purpose for which it is appropriate to use RADTs and summarises key considerations for their implementation. Reaching an agreement on settings and performance criteria will be critical for the success of EU/EEA-wide surveillance purposes and for measures related to cross-border travel.